Patient and Surgical Factors Influencing Air Leak After Lung Volume Reduction Surgery: Lessons Learned From the National Emphysema Treatment Trial Malcolm.

Slides:

Advertisements

Similar presentations

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Advertisements

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Photodynamic Laser Therapy for Lesions in the Airway

Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema by the National Emphysema Treatment.

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Characterization and Importance of Air Leak After Lobectomy

Moderate Tricuspid Regurgitation With Left-Sided Degenerative Heart Valve Disease: To Repair or Not to Repair? Jose L. Navia, MD, Nicolas A. Brozzi,

Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database

Long-Term Follow-Up of Patients Receiving Lung-Volume-Reduction Surgery Versus Medical Therapy for Severe Emphysema by the National Emphysema Treatment.

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Trevor Williams, MD, MPH, Brian C

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Mortality Risk and Pulmonary Function in Adults With Cystic Fibrosis at Time of Wait Listing for Lung Transplantation Don Hayes, MD, MS, Stephen Kirkby,

Robert J Cerfolio, MD, Cyndi Bass, MSN, Charles R Katholi, PhD

The Validation of a No-Drain Policy After Thoracoscopic Major Lung Resection Junichi Murakami, MD, PhD, Kazuhiro Ueda, MD, PhD, Toshiki Tanaka, MD, PhD,

Effect of changes in postoperative spirometry on survival after lung transplantation David P. Mason, MD, Jeevanantham Rajeswaran, MSc, Liang Li, PhD,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Richard P. Whitlock, MD, Mark.

Mitral Valve Surgery in the Adult Marfan Syndrome Patient

David P. Mason, MD, Jeevanantham Rajeswaran, MS, Sudish C

Surgical Treatment of Postinfarction Left Ventricular Pseudoaneurysm

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Surgery for coarctation of the aorta in infants weighing less than 2 kg Emile A Bacha, MD, Melvin Almodovar, MD, David L Wessel, MD, David Zurakowski,

An Evidence-Based Estimate on the Size of the Potential Patient Pool for Lung Volume Reduction Surgery Praveen Akuthota, MD, Diana Litmanovich, MD, Moshe.

Reoperation After Mitral Valve Repair for Degenerative Disease

Bruce W. Lytle, MD, Eugene H. Blackstone, MD, Joseph F

Operative Results and Outcomes in Children With Shone's Anomaly

Aortic Valve Replacement Improves Survival in Severe Aortic Stenosis Associated With Severe Pulmonary Hypertension Ramdas G. Pai, MD, Padmini Varadarajan,

Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair Douglas R. Johnston, MD, A. Marc Gillinov, MD,

Vibration Response Imaging in Prediction of Pulmonary Function After Pulmonary Resection Hyun Koo Kim, MD, PhD, DaeGwang Yoo, MD, Ho Kyung Sung, MD,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Amedeo Anselmi, MD, Gianfederico Possati, MD, Mario Gaudino, MD

Outcome After Lung Volume Reduction Surgery in Patients With Severely Impaired Diffusion Capacity Claudio Caviezel, MD, Nadja Schaffter, Didier Schneiter,

Trevor Williams, MD, MPH, Brian C

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Use of Amiodarone After Major Lung Resection

Outcomes of less invasive J-incision approach to aortic valve surgery

David P. Mason, MD, Lillian H. Batizy, MS, Jeffrey Wu, MD, Edward R

Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer Malcolm M DeCamp, MD, Thomas W Rice, MD, David J Adelstein,

Comparative study of bronchial artery revascularization in lung transplantation Gösta B. Pettersson, MD, PhD, Karam Karam, MD, Lucy Thuita, MS, Douglas.

Sudish C. Murthy, MD, PhD, Edward R. Nowicki, MD, MS, David P

Lung Function and ECMO After Lung Transplantation

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

David P. Mason, MD, Dale H. Marsh, MD, Joan M. Alster, MS, Sudish C

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Cardiac Arrhythmia After Open Thoracoabdominal Aortic Aneurysm Repair

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

The Association of Chronic Lung Disease With Early Mortality and Respiratory Adverse Events After Aortic Valve Replacement Juan A. Crestanello, MD, Robert.

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Thomas W. Rice, MD, Deepak Khuntia, MD, Lisa A. Rybicki, MS, David J

Mohammed A Quader, MD, Patrick M McCarthy, MD, A

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Rheumatoid Pleural Effusion in the Absence of Arthritic Disease

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Turki B. Albacker, MD, MSc, Eugene H. Blackstone, MD, Sarah J

Correction of Tetralogy of Fallot and of Pulmonary Atresia with Ventricular Septal Defect in Adults Jürgen Hörer, MD, Julia Friebe, MD, Christian Schreiber,

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

The Removal of Chest Tubes Despite an Air Leak or a Pneumothorax

Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results Alberto Pochettino, MD, Robert M Kotloff,

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Total Anomalous Pulmonary Venous Connection: An Analysis of Current Management Strategies in a Single Institution Camille L. Hancock Friesen, MD, David.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Mark I. Block, MD The Annals of Thoracic Surgery

Lung Transplantation for Idiopathic Pulmonary Fibrosis

Fernando A. Atik, MD, Lars G. Svensson, MD, PhD, FACC, Eugene H

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Presentation transcript:

Patient and Surgical Factors Influencing Air Leak After Lung Volume Reduction Surgery: Lessons Learned From the National Emphysema Treatment Trial Malcolm M. DeCamp, MD, Eugene H. Blackstone, MD, Keith S. Naunheim, MD, Mark J. Krasna, MD, Douglas E. Wood, MD, PhD, Yvonne M. Meli, RN, Robert J. McKenna, MD The Annals of Thoracic Surgery Volume 82, Issue 1, Pages 197-207 (July 2006) DOI: 10.1016/j.athoracsur.2006.02.050 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Among patients experiencing air leaks after closure at any time during the first 30 days after lung volume reduction surgery, the number that stopped on each day. Air leak persisting at least 30 days is shown in the extreme right-hand bar. The Annals of Thoracic Surgery 2006 82, 197-207DOI: (10.1016/j.athoracsur.2006.02.050) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Relation of patient, disease management, pulmonary function, and disease factors to duration of air leak among patients in whom air leak occurred within 30 days of lung volume reduction surgery. Step graphs represent Kaplan-Meier survival-type estimates because data were censored at 30 days and at death (if air leak persisted until that time) within 30 days. Vertical bars represent asymmetric 68% confidence limits equivalent to ±1 standard error. Numbers in parentheses are number remaining with air leak at that interval. A higher line indicates more prolonged air leak, a lower line shorter air leak. (A) Caucasian (□, n = 469) versus other ethnicities (○, n = 24). (B) Use of inhaled steroids (□, n = 350) versus no inhaled steroids (○, n = 143). (C) Diffusing capacity (percent of predicted; ○ ≤ 20, n = 119; □ = 20 to 30, n = 197; ▵ = 30 to 40, n = 126; ♢ > 40, n = 51). Number of patients remaining with air leaks at various time points is not shown because of busyness of the figure. (D) One-second forced expiratory volume (FEV1, percent of predicted; ○ = ≤20, n = 103; □ = 20 to 30, n = 239; ▵ = >30; n = 151). (E) Distribution of disease, lower lobe (□, n = 59) versus other (○, n = 359). (F) Presence (□, n = 213) or absence (○, n = 279) of moderate or severe pleural adhesions. The Annals of Thoracic Surgery 2006 82, 197-207DOI: (10.1016/j.athoracsur.2006.02.050) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Postoperative length of stay in 54 pairs of propensity-matched patients who either did (□) or did not (○) experience air leak in the 30 days after lung volume reduction surgery. Depiction is as in Fig 2. The Annals of Thoracic Surgery 2006 82, 197-207DOI: (10.1016/j.athoracsur.2006.02.050) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions